| Date Filed | Type | Description |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2023 |
3
| HASTINGS DAVID C (Director) has filed a Form 3 on Vascular Biogenics Ltd. |
| 07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 10,000 options to buy
@ $1.78, valued at
$17.8k
|
|
| 02/15/2022 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 12,060 options to buy
@ $6.85, valued at
$82.6k
Granted 9,276 options to buy
@ $2.44, valued at
$22.6k
Disposed/sold 15,000 options to buy
@ $5.66, valued at
$84.9k
Granted 11,538 options to buy
@ $2.44, valued at
$28.2k
Disposed/sold 7,500 options to buy
@ $6.12, valued at
$45.9k
Granted 5,769 options to buy
@ $2.44, valued at
$14.1k
|
|
| 01/20/2022 |
4
| HASTINGS DAVID C (CFO) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 285,000 options to buy
@ $2.81, valued at
$800.9k
|
|
| 01/19/2022 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 27,500 shares
@ $0 |
|
| 06/21/2021 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 10,000 options to buy
@ $7.51, valued at
$75.1k
|
|
| 04/02/2021 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 22,000 shares
@ $0 |
|
| 03/31/2021 |
4/A
| HASTINGS DAVID C (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 55,000 options to buy
@ $0.73, valued at
$40.2k
|
|
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2020 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 45,000 options to buy
@ $0.73, valued at
$32.9k
|
|
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2019 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 7,500 options to buy
@ $6.12, valued at
$45.9k
|
|
| 06/20/2019 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 45,000 options to buy
@ $1.29, valued at
$58.1k
|
|
| 03/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2019 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.66, valued at
$84.9k
|
|
| 01/04/2019 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 22,500 options to buy
@ $0.5441, valued at
$12.2k
|
|
| 09/25/2018 |
3
| HASTINGS DAVID C (Director) has filed a Form 3 on Entasis Therapeutics Holdings Inc. |
| 06/21/2018 |
4
| HASTINGS DAVID C (CFO) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 200,000 options to buy
@ $6.75, valued at
$1.4M
|
|
| 06/21/2018 |
3
| HASTINGS DAVID C (CFO) has filed a Form 3 on Arbutus Biopharma Corp |
| 03/12/2018 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Bought 11,834 shares
@ $1.69, valued at
$20k
Bought 8,875 warrants
@ $1.85, valued at
$16.4k
Bought 5,325 warrants
@ $2, valued at
$10.7k
|
|
| 01/04/2018 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 19,989 options to buy
@ $2.28, valued at
$45.6k
|
|
| 06/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/30/2017 |
4
| HASTINGS DAVID C (See Remarks) has filed a Form 4 on Unilife Corp |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/28/2015 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on SCYNEXIS INC|
Txns:
| Granted 11,700 options to buy
@ $6.89, valued at
$80.6k
|
|
| 02/25/2015 |
4
| HASTINGS DAVID C (See Remarks) has filed a Form 4 on Unilife Corp|
Txns:
| Granted 300,000 shares
@ $0 |
|
| 06/06/2014 |
4
| HASTINGS DAVID C (CFO) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 76,034 shares
@ $52.61, valued at
$4M
Sold 123,966 shares
@ $52.81, valued at
$6.5M
Exercised 6,500 options to buy
@ $17.79, valued at
$115.6k
Exercised 43,500 options to buy
@ $14.72, valued at
$640.3k
Exercised 7,500 options to buy
@ $13.34, valued at
$100.1k
Exercised 18,534 options to buy
@ $9.41, valued at
$174.4k
Exercised 23,966 options to buy
@ $9.41, valued at
$225.5k
Exercised 50,000 options to buy
@ $3.11, valued at
$155.5k
Exercised 50,000 options to buy
@ $5.46, valued at
$273k
|
|
| 02/18/2014 |
4
| HASTINGS DAVID C (CFO) has filed a Form 4 on INCYTE CORP|
Txns:
| Sold 202,999 shares
@ $66.12, valued at
$13.4M
Sold 40,000 shares
@ $64.74, valued at
$2.6M
Sold 32,001 shares
@ $65.64, valued at
$2.1M
Exercised 7,999 options to buy
@ $8.99, valued at
$71.9k
Exercised 9,665 options to buy
@ $11.98, valued at
$115.8k
Exercised 13,000 options to buy
@ $14.72, valued at
$191.4k
Exercised 16,000 options to buy
@ $18.32, valued at
$293.1k
Exercised 90,335 options to buy
@ $11.98, valued at
$1.1M
Exercised 66,000 options to buy
@ $17.79, valued at
$1.2M
Exercised 34,964 options to buy
@ $8.99, valued at
$314.3k
Exercised 5,036 options to buy
@ $8.99, valued at
$45.3k
|
|
| 01/23/2014 |
4
| HASTINGS DAVID C (CFO) has filed a Form 4 on INCYTE CORP|
Txns:
| Granted 1,450 options to buy
@ $64.55, valued at
$93.6k
Granted 23,379 options to buy
@ $64.55, valued at
$1.5M
|
|
| 09/09/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|